Sable Therapeutics
NY - New YorkBiotechnology
Focus: Sable Therapeutics is a public-stage biotechnology company headquartered in New York specializing in fat reduction therapies with a focus on neurological applications.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
6+1 this month
Stable — net +1 jobs in 30d
6 added, 5 removed. Backfill posture.
Should You Work at Sable Therapeutics?
AI assessmentSable presents as an early-stage, pre-revenue biotech with differentiated biology but minimal visible clinical progress or hiring momentum — suited for high-risk tolerance candidates betting on early platform validation rather than near-term career advancement.
Why Work Here
- Public company status provides liquidity and institutional stability for equity-based compensation
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Sable Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.